Scott Sukenick

Scott Sukenick

General Counsel at SCYNEXIS, Inc.

Are you Scott Sukenick? Claim your profile
 
  • IDENTIFY executive and board member connections in Scott Sukenick's network.
  • FOLLOW changes in Scott Sukenick's employment.
  • CONNECT with Scott Sukenick through your network of contacts.

Scott Sukenick's Executive Work History


Current
General Counsel,
General Counsel
Equilar on 04/28/2022
SCYNEXIS, Inc.
Past
To view Scott Sukenick's complete executive work history,
 

Scott Sukenick's Biography


Mr. Sukenick joined SCYNEXIS as General Counsel in November 2017 after over a decade of addressing a diversity of legal challenges faced by innovative life sciences companies at all stages of development. Mr. Sukenick most recently worked at Cooley LLP, where he focused on life sciences litigation and strategic intellectual property management. Prior to that, he worked at Patterson Belknap Webb & Tyler LLP, where he primarily represented pharmaceutical and medical device companies in patent litigation. He started his career at Simpson Thacher & Bartlett LLP, where his practice focused on complex commercial litigation and intellectual property transactional matters. Mr. Sukenick is a registered patent attorney. He obtained a B.S. in Biology and a B.A. in Chemistry from Duke University and a J.D. from Harvard University.

Source: SCYNEXIS, Inc. on 12/28/2022

 

By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like Scott Sukenick. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in Scott Sukenick's network.
  • FOLLOW changes in Scott Sukenick's employment.
  • CONNECT with Scott Sukenick through your network of contacts.
 

Access over 1,500,000 executive and board member profiles.

Example: Scott Sukenick

Scott Sukenick's Connections (16)


Glen D. Park PharmD MSJ
Vice President, Regulatory Affairs & Quality Assurance, SCYNEXIS, Inc.
Christine Coyne
Former Chief Commercial Officer, SCYNEXIS, Inc.
Brian Philippe Tinmouth
Chief Business and Strategy Officer, Mammoth Biosciences, Inc
Eric Francois
Former Chief Financial Officer, SCYNEXIS, Inc.
Ann F. Hanham Ph.D.
Chairman, HTG Molecular Diagnostics, Inc.
Armando Anido
Chairman of the Board and Chief Executive Officer, Zynerba Pharmaceuticals, Inc.
Marco Taglietti M.D.
President, Chief Executive Officer and Director, SCYNEXIS, Inc.
Jim Maffezzoli
Former Vice President, Marketing and Sales, SCYNEXIS, Inc.
Lawrence R. Hoffman
Interim Chief Financial Officer, SCYNEXIS, Inc.
David C. Hastings
Chief Financial Officer, Arbutus Biopharma Corporation